PET Community Coalesces For Alzheimer’s Disease Diagnosis Coverage
This article was originally published in The Gray Sheet
Executive Summary
Reimbursement of positron emission tomography for diagnosing Alzheimer's disease will be contingent on the PET community's mobilization and grassroots efforts, according to Rep. Nancy Johnson (R-Conn.)
You may also be interested in...
Industry Technology Training Role Poses Conflict Of Interest – Mayo Surgeon
Potential conflicts of interest between surgeons and device companies are underscored by the rising influence of new technology on vascular practice, according to Tim Sullivan, MD, Mayo Clinic
PET Expert Panel Scans Alzheimer’s National Coverage Options
CMS is considering limiting reimbursement of FDG PET for Alzheimer's disease diagnosis to specific clinical trial participants, according to Coverage & Analysis Group Director Steve Phurrough, MD
PET Expert Panel Scans Alzheimer’s National Coverage Options
CMS is considering limiting reimbursement of FDG PET for Alzheimer's disease diagnosis to specific clinical trial participants, according to Coverage & Analysis Group Director Steve Phurrough, MD